ScanSource submits current report to SEC
Rhea-AI Filing Summary
SCANSOURCE, INC. (symbol: SCSC) is the issuer of record for a Form 8-K filing submitted to the SEC.
Positive
- None.
Negative
- None.
Filing Explained
The closed MicroAge purchase was financed with approximately $225 million of revolving borrowings, making new debt the filing’s key structural change.
The
The
Of the purchase price,
For scale, the latest reported quarter ended
The press release says the transaction is expected to improve gross profit margin, adjusted EBITDA margin, non-GAAP EPS and free cash flow in the first year after closing, while identifying integration and failure to realize those benefits as risks.
8-K Event Classification
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| (Address of principal executive offices) | (Zip code) |
Registrant’s telephone number, including area code:
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbol |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
On September 1, 2026, ScanSource, Inc. (the “Company”) completed its previously announced acquisition of all of the issued and outstanding capital stock of MicroAge Acquisition Corp. (“MicroAge”). Subject to customary post-closing working capital adjustments, the purchase price consisted of $220.5 million paid in cash at closing, with $3 million and $6.8 million held in escrow to support the post-closing obligations of the Sellers to satisfy any purchase price adjustments and cover any post-closing indemnification claims, respectively.
The Company paid the cash consideration using borrowings under its revolving credit facility established pursuant to that certain Credit Agreement, dated December 18, 2025, by and among the Company, certain of its subsidiaries party thereto, as subsidiary borrowers, the lenders party thereto, and PNC Bank National Association, as administrative agent (the “Credit Agreement”). The Company borrowed approximately $225 million under the revolving credit facility in connection with the closing of the MicroAge acquisition.
The foregoing description of the Credit Agreement does not purport to be complete and is qualified in its entirety by reference to the Credit Agreement, a copy of which was attached as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on December 19, 2025, and the terms of which are incorporated by reference herein.
Item 7.01. Regulation FD Disclosure
On September 2, 2026, the Company issued a press release announcing the completion of its previously announced acquisition of MicroAge. A copy of the press release is attached as Exhibit 99.1 hereto, incorporated by reference herein and also made available through the Company’s website at www.scansource.com.
The information in Item 7.01 of this Current Report on Form 8-K, including Exhibits 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deeded incorporated by reference in any other filing under the Securities Act of 1933, as amended, or the Exchange Act.
| Item 9.01. | Financial Statements and Exhibits. |
| (d) | Exhibits |
| Exhibit Number | Description | |
| 99.1 | Press Release | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ScanSource, Inc. | ||||||
| Date:September 2, 2026 | /s/ Michael L. Baur | |||||
| Michael L. Baur | ||||||
| President & Chief Executive Officer | ||||||
Exhibit 99.1
For Release:
September 2, 2026
Press Contact:
Natalyn Klump
Natalyn.Klump@scansource.com
Investor Contact:
Mary Gentry
mary.gentry@scansource.com
ScanSource Completes Acquisition of MicroAge
GREENVILLE, SC – ScanSource, Inc. (NASDAQ: SCSC), a leading technology distributor uniquely positioned to address complex technologies, today announced the successful completion of its acquisition of MicroAge, pursuant to the definitive agreement previously announced on August 20, 2026.
“The acquisition of MicroAge marks an exciting milestone in ScanSource’s growth journey,” said Mike Baur, Chair and CEO, ScanSource, Inc. “This transaction advances our strategic priorities and strengthens our ability to serve customers and create long-term value for shareholders.”
Under the terms of the agreement, ScanSource acquired MicroAge in an all-cash transaction for a purchase price of $220.5 million, funded through borrowings under its existing credit facility. As previously announced, the transaction is expected to be accretive to gross profit margin, adjusted EBITDA margin, and non-GAAP EPS in the first year following close, and is also expected to be free cash flow positive for ScanSource.
For more information on ScanSource, visit here.
About ScanSource, Inc.
ScanSource, Inc. (NASDAQ: SCSC) is a leading technology distributor uniquely positioned to address complex technologies and to accelerate growth for channel sales partners across hardware, software as a service (SaaS), connectivity and cloud services. ScanSource enables channel sales partners to deliver converging solutions for their end users. ScanSource uses multiple sales models to offer technology solutions from leading suppliers of specialty technologies, connectivity and cloud services. Founded in 1992 and headquartered in Greenville, South Carolina, ScanSource was named one of the 2025 Best Places to Work in South Carolina and on the Fortune World’s Most Admired Companies 2026 List. ScanSource ranks #923 on the Fortune 1000. For more information, visit www.scansource.com.
About MicroAge
MicroAge is an award-winning full-service solutions integrator. For 50 years, MicroAge has empowered businesses to advance, secure, accelerate, and transform—moving quickly with technology changes across the channel to drive business forward. Our elite, highly certified team of specialized consultants brings unique expertise to our clients in cybersecurity, data intelligence, technology implementations, managed IT services, and more. Visit www.microage.com to learn more.
Forward-Looking Statements
This press release contains, or may be deemed to contain, “forward-looking statements” (as defined in the U.S. Private Securities Litigation Reform Act of 1995, as amended). These forward-looking statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These risks and other factors include the risks and uncertainties inherent in the transactions contemplated by the MicroAge Purchase Agreement and in the Company’s business, including, without limitation, the ability of the Company to successfully integrate MicroAge into its business and the risk that the Company will fail to realize the expected benefits of the acquisition (including accretion to gross profit margin, adjusted EBITDA margin and non-GAAP EPS). Other important factors that could cause actual results to differ materially from the Company’s expectations are set forth under the caption “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2026. In light of these risks, uncertainties, and other factors, the forward-looking statements might not prove to be accurate and you should not place undue reliance upon them. All forward-looking statements speak only as of the date made and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.